Products
Active Pharmaceutical Ingredients
Product |
CAS NO. |
Therapeutic Category |
CHINA |
US |
EU |
JAPAN |
OTHERS |
Aprepitant |
170729-80-3 |
Oncology |
▲ |
▲ |
CEP |
▲ |
CTD |
Bisoprolol Fumarate |
104344-23-2 |
Cardiovascular |
GMP |
|
CEP |
JDMF |
CTD |
Brexpiprazole |
913611-97-9 |
Neurology & Psychiatry |
▲ |
|
|
|
TP |
Dabigatran Etexilate Mesylate |
872728-81-9 |
Cardiovascular |
Approved |
USDMF |
▲ |
JDMF |
CTD |
Dabigatran Etexilate Mesylate Pellet |
872728-81-9 |
Cardiovascular |
Approved |
|
|
|
CTD |
Ibandronate Sodium |
138926-19-9 |
Oncology |
GMP |
|
|
|
TP |
Lenvatinib Mesylate |
417716-92-8 |
Oncology |
▲ |
▲ |
▲ |
▲ |
TP |
Parecoxib Sodium |
198470-85-8 |
Anesthetic & Analgesics |
GMP |
|
|
|
CTD |
Rotigotine |
99755-59-6 |
Neurology & Psychiatry |
▲ |
▲ |
▲ |
▲ |
CTD |
Silodosin |
160970-54-7 |
Urinary system |
▲ |
|
▲ |
JDMF |
CTD |
Sodium Fusidate |
751-94-0 |
Anti-inflammatory |
GMP |
|
|
|
CTD |
Sugammadex Sodium |
343306-79-6 |
Anesthetic & Analgesics |
Under Approval |
|
▲ |
|
CTD |
Ticagrelor |
274693-27-5 |
Cardiovascular |
Under Approval |
USDMF |
▲ |
▲ |
CTD |
Ubenimex |
58970-76-6 |
Oncology |
GMP |
|
|
JDMF |
CTD |
▲ CTD dossier under filling/preparation
According to laws and regulations of People's Republic of China, relevant information of Schedule II Controlled Substance APIs is not released here.
Disclaimer: The product that is still under patent protection can only be used in research and development, not for commercial purpose.